EOFlow today announced a January re-launch of its technology-driven operations, expanding both its connected diabetes care ecosystem and technology-enabled recovery services.
As part of the January re-launch, EOFlow is reintroducing its operations using the same technology-first principles that underpin both its restoration services and connected health platforms. The updated model incorporates advanced diagnostic tools, precision assessment technologies, and rapid-response protocols, while also supporting continued integration of the Narsha App with the flagship EOFlow EOPatch wearable insulin delivery system. Often referred to as the EOFlow patch pump, the device enables tubeless, disposable insulin administration supported by real-time data intelligence, continuous safety monitoring, automated alerts, and intelligent insulin optimization. Digital coordination and operational visibility across these technology-driven operations are further supported through platforms such as the Nashra App.
“Our expansion reflects a broader vision,” said EOFlow leadership. “Whether addressing diabetes management or recovery challenges, the goal is to combine real-time intelligence, advanced technology, and human expertise to reduce risk and improve outcomes.”
With the enhanced integration, the Narsha App and EOFlow pump operate as a synchronized system, aligning with company background information that emphasizes EOFlow’s focus on precision engineering and user-centered insulin delivery. Users can view glucose trends, insulin delivery history, and lifestyle-related insights within a single dashboard for continuous visibility into daily therapy management. Using secure Bluetooth Low Energy communication, the EOFlow EOPatch continuously transmits real-time insulin activity, delivery adjustments, reservoir and battery status, and critical alerts throughout the day.
In addition, the Narsha App supports selected continuous glucose monitors and smart glucose meters, linking food intake, exercise, sleep, and stress patterns with real-time glucose data, while predictive intelligence analyzes long-term trends to provide early warnings of potential glucose changes. System updates occur every few minutes, immediately alerting users to issues such as low reservoir levels, occlusions, adhesion problems, or insulin transfer inconsistencies, enabling timely response before glucose levels are affected, particularly during sleep or physical activity.
To support data protection and clinical collaboration, EOFlow’s platform uses encrypted communication and secure cloud storage aligned with HIPAA, GDPR, and international compliance standards. Users may also choose to share data with healthcare providers for remote monitoring and personalized treatment planning. Additional details on EOFlow’s connected health platforms and digital infrastructure are available through EOFlow’s official website.
To support secure and scalable digital operations, blockchain-based architecture is being integrated to strengthen data integrity, enable secure device authentication, and support controlled data sharing across EOFlow’s connected platforms, including insulin delivery systems and related device data.
Anchored by this technology-first approach, EOFlow operates under the leadership of Founder and CEO Jesse J. Kim is an MIT-trained electrical engineer who has guided the development and commercialization of the EOPatch since EOFlow’s founding in 2011. Under his leadership, EOFlow has expanded into connected digital health platforms, reinforcing the company’s position as a credible innovator in insulin delivery and data-driven healthcare solutions.
To learn more about EOFlow’s connected health platforms, wearable insulin delivery systems, and technology-driven recovery solutions, visit https://eoflow.com/.
About EOFlow
EOFlow Co., Ltd. is a South Korea–based medical technology company redefining how insulin delivery and connected health systems operate in real time. Founded in 2011, EOFlow designs wearable insulin delivery platforms that integrate precision engineering, data intelligence, and user-centered design. Through its EOPatch system and connected digital platforms, EOFlow continues to advance scalable solutions that support accuracy, safety, and control in daily diabetes management and technology-driven recovery operations.
###
Media Contact
EOFlow Communications Team
Address: 302, 216 Hwangsaeul-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea
Phone: 031-738-0200
Website: https://eoflow.com/
Source: 38 Digital Market News
Release ID: 2015657
